With the continuous development of cancer treatment, patients with cancer have dramatically improved, with several cancer populations experiencing a median survival well beyond 5 years.1 However, malignancy cancer has an innegligible impact on the cardiovascular system, not only the cancer itself, but also the adverse effects of treatments (drugs or radiation). Recently, increasing data have shown that cancer survivors have increased rates of major cardiovascular events, including cardiac arrest, with poorer outcomes.